Stocks Health care NPHC

OTC · Health care

Nutra Pharma Corp (NPHC)

Nutra Pharma Corp brought in $160.8K of revenue over the twelve months to June 30, 2026, down 49.0% from a year earlier. It posted a net loss of $5.4M. In fiscal 2025 capital spending exceeded operating cash flow by $1.2M. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 19, 2026.

Watch NPHC in 60 seconds

What Nutra Pharma Corp does

Nutra Pharma Corp is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker NPHC.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Where NPHC ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Nutra Pharma Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 2, 2026
   Change in control 8-K
2. September 1, 2026
   Activist stake (5% or more) SCHEDULE 13D
3. August 19, 2026
   Quarterly report 10-Q · period to June 30, 2026Revenue fell 59% to $34.5K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
4. August 14, 2026
   Late quarterly report notice NT 10-Q
5. May 29, 2026
   Quarterly report 10-Q · period to March 31, 2026Revenue fell 63% to $27.2K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
6. May 20, 2026
   Annual report 10-K · period to December 31, 2025Revenue rose 4.6% to $257.6K versus the prior year; diluted EPS $0.00 versus $0.00.
7. April 6, 2026
   Quarterly report 10-Q · period to September 30, 2025Revenue fell 6.3% to $70.2K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
8. March 25, 2026
   Quarterly report 10-Q · period to June 30, 2025Revenue was $84.5K; diluted EPS was $0.00.
9. March 11, 2026
   Quarterly report 10-Q · period to March 31, 2025Revenue was $74K; diluted EPS was $0.00.
10. February 17, 2026
    Annual report 10-K · period to December 31, 2024Revenue rose 20% to $246.3K versus the prior year; diluted EPS $0.00 versus $0.00.

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 1, 2026. Insider transactions on SEC

Insider trades

What the people running Nutra Pharma Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns NPHC

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about NPHC

What does Nutra Pharma Corp do?

Nutra Pharma Corp is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker NPHC.

Is Nutra Pharma Corp profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $5.4M on revenue of $160.8K.

How much revenue does Nutra Pharma Corp make?

Over the twelve months to June 30, 2026 Nutra Pharma Corp reported revenue of $160.8K. That is 49.0% less than a year earlier.

When did Nutra Pharma Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 19, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the change in control from September 2, 2026.

Similar companies

Compare NPHC with

Compare NPHC with any company

Follow NPHC

Get an email when Nutra Pharma Corp files with the SEC: results, executive changes, material agreements and annual reports.

Follow NPHC: get an email when it files

Where the numbers come from

Financial figures are the values Nutra Pharma Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.